To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out MoreTIDM | BPCR |
---|---|
Ticker Code | BPCR.L |
ISIN | GB00BDGKMY29 |
Currency | USD |
Issue Country | GB |
Sector | NMX302040 |
Year End | 31-Dec-22 |
Shares in Issue | 1.22b |
---|---|
Market Cap. | $1.07b |
Market Size | 20,000 |
PE Ratio | 10.60386 |
Earnings | 0.0828 |
Dividend | 0.0525 |
Yield | 5.979% |
# of Trades | 75 |
---|---|
Vol Sold | 998,957 |
Vol Bought | 435,847 |
52 Week High | 0.966 |
52 Week High Date | 17-May-2023 |
52 Week Low | 0.81 |
52 Week Low Date | 09-Nov-2023 |
Standard | GAAP | GAAP | GAAP | GAAP | GAAP |
---|---|---|---|---|---|
Millions | Millions | Millions | Millions | Millions | |
Income Statement | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 |
Turnover | 212.22 | 127.63 | 100.55 | 142.34 | 96.67 |
Operating Profit / Loss | 176.39 | 108.73 | 79.67 | 113.82 | 73.63 |
Net Interest | n/a | n/a | n/a | n/a | n/a |
Pre Tax Profit | 176.39 | 108.73 | 79.67 | 113.82 | 69.95 |
Post Tax Profit | 176.39 | 108.73 | 79.67 | 113.82 | 69.95 |
Continuing EPS | |||||
Earnings per Share (Basic) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Earnings per Share (Diluted) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Earnings per Share (Adjusted) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Continuing and Discontinued EPS | |||||
Earnings per Share (Basic) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Earnings per Share (Diluted) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Earnings per Share (Adjusted) | 12.93USX | 7.91USX | 5.80USX | 8.28USX | 7.07USX |
Dividend per Share | $0.10 | $0.07 | $0.07 | $0.07 | $0.07 |
Millions | Millions | Millions | Millions | Millions | |
Balance Sheet | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 |
Non-Current Assets | |||||
Intangible Assets | n/a | n/a | n/a | n/a | n/a |
Tangible Assets | n/a | n/a | n/a | n/a | n/a |
Fixed Investments | 1.22 | 1.27 | 1,194.83 | 1,116.13 | 1,008.25 |
Total Fixed Assets | 1.22 | 1.27 | 1,194.83 | 1,116.13 | 1,008.25 |
Current Assets | |||||
Stocks | n/a | n/a | n/a | n/a | n/a |
Debtors | 0.02 | 0.01 | 0.21 | 16.21 | 21.45 |
Cash at Bank and in Hand | 0.12 | 0.09 | 193.27 | 296.64 | 363.57 |
Total Assets | 1.36 | 1.37 | 1,388.31 | 1,428.97 | 1,393.27 |
Current Liabilities | |||||
Creditors Within 1Yr | 0.03 | 0.01 | 9.39 | 24.50 | 5.46 |
Net Current Assets | 0.11 | 0.09 | 184.08 | 288.34 | 379.56 |
Non-Current Liabilities | |||||
Creditors After 1Yr | n/a | n/a | n/a | n/a | 7.79 |
Net Assets | 1.34 | 1.36 | 1,378.92 | 1,403.74 | 1,380.02 |
Capital and Reserves | |||||
Called Up Share Capital | 0.01 | 0.01 | 13.74 | 13.74 | 13.74 |
Share Premium Account | 0.61 | 0.61 | 607.12 | 607.12 | 607.12 |
Other Reserves | 0.67 | 0.72 | 750.51 | 741.18 | 736.35 |
Shareholders Funds | 1.34 | 1.36 | 1,378.92 | 1,403.74 | 1,380.02 |
Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 | |
Operating Margin | 83.12% | 85.19% | 79.23% | 79.96% | 76.16% |
Return on Capital Employed | 13,188.73% | 7,973.06% | 5.78% | 8.11% | 5.07% |
Dividend Cover | 1.85 | 1.13 | 0.83 | 1.18 | 1.02 |
Dividend Yield | 7.40 | 7.20 | 7.00 | 6.90 | 6.50 |
PE Ratio | 7.30 | 12.20 | 17.20 | 12.30 | 15.10 |
PEG | n/a | n/a | n/a | 0.30 | n/a |
Dividend per Share Growth | n/a | n/a | n/a | n/a | (0.86%) |
Net Asset Value per Share | $0.00 | $0.00 | $1.06 | $1.08 | $1.06 |